Literature DB >> 16387568

Relation of endothelial cell function to erectile dysfunction: implications for treatment.

André T Guay1.   

Abstract

The prevalence of both cardiovascular disease (CVD) and erectile dysfunction (ED) increases with advancing age. These conditions share the common risk factors of diabetes mellitus, hypertension, hyperlipidemia, smoking, and obesity. They also share a pathophysiologic mechanism of decreased vascular blood flow via endothelial dysfunction. There are several lines of evidence that endothelial dysfunction in men with ED can be detected well before overt manifestations of vascular damage, including atherosclerotic effects. Some evidence shows that ED can be improved not only with phosphodiesterase 5 inhibitors but also by treating the risk factors directly. This includes cessation of smoking, correction of hyperlipidemia, and amelioration of obesity through weight loss. Conversely, ED may be prevented through maintenance of lean body mass, consistency of physical activity, and smoking abstinence, similar to other risk factors for CVD.

Entities:  

Mesh:

Year:  2005        PMID: 16387568     DOI: 10.1016/j.amjcard.2005.10.006

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score?

Authors:  Andre B Araujo; Susan A Hall; Peter Ganz; Gretchen R Chiu; Raymond C Rosen; Varant Kupelian; Thomas G Travison; John B McKinlay
Journal:  J Am Coll Cardiol       Date:  2010-01-26       Impact factor: 24.094

2.  Risk factors for incident erectile dysfunction among community-dwelling men.

Authors:  Susan A Hall; Rebecca Shackelton; Raymond C Rosen; Andre B Araujo
Journal:  J Sex Med       Date:  2009-11-19       Impact factor: 3.802

3.  Erectile dysfunction and mortality.

Authors:  Andre B Araujo; Thomas G Travison; Peter Ganz; Gretchen R Chiu; Varant Kupelian; Raymond C Rosen; Susan A Hall; John B McKinlay
Journal:  J Sex Med       Date:  2009-06-15       Impact factor: 3.802

Review 4.  Diagnosing erectile dysfunction could save your patient's life.

Authors:  Gerald Brock
Journal:  Can Urol Assoc J       Date:  2014-07       Impact factor: 1.862

5.  Low-dose spironolactone reduces plasma fibulin-1 levels in patients with type 2 diabetes and resistant hypertension.

Authors:  C S Oxlund; C Cangemi; J E Henriksen; I A Jacobsen; J Gram; K Schousboe; L Tarnow; W S Argraves; L M Rasmussen
Journal:  J Hum Hypertens       Date:  2014-04-17       Impact factor: 3.012

6.  A long-term "memory" of HIF induction in response to chronic mild decreased oxygen after oxygen normalization.

Authors:  Chandrashekhar D Kamat; Jessica E Thorpe; Satyendra S Shenoy; Antonio Ceriello; Dixy E Green; Linda A Warnke; Michael A Ihnat
Journal:  BMC Cardiovasc Disord       Date:  2007-01-18       Impact factor: 2.298

Review 7.  Can lifestyle modification affect men's erectile function?

Authors:  Marah C Hehemann; James A Kashanian
Journal:  Transl Androl Urol       Date:  2016-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.